Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

A3 antibody helps identify key cells in rat hair follicle development.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Cow colostrum and milk can effectively produce anti-hair keratin antibodies.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.